1. Fe2O3@SiO2@Eu-MOF@Tb-MOF Core/Multishell Nanoparticles for the Fluorescence Sensing of Aspirin and Acute Myocardial Infarction Biomarkers.
- Author
-
Shi, Yang Fan, Jiang, Yu Peng, Wang, Xing Ze, Zhang, Zi Qing, Huo, Jian Zhong, Liu, Yuan Yuan, Wang, Xin Rui, and Ding, Bin
- Abstract
As a dangerous cardiovascular disease, acute myocardial infarction (AMI) has taken the lives of countless patients. Symptom onset of AMI is accompanied by a high amount of AMI biomarkers, including creatine kinase isoenzyme (CK-MB), troponin I (CTn I), and myoglobin (Mb). On the other hand, aspirin is an effective curing drug for AMI. Herein, we applied the layer-by-layer (LBL) synthesis strategy to form stratified magnetic core/multishell lanthanide metal–organic framework (Ln-MOF) Fe
2 O3 @SiO2 @Eu-MOF@Tb-MOF (MagMOF) nanoballs. Further, target mRNA sequence and antibodies (NH2 -mRNA, anti-CTn, and anti-Mb) for AMI biomarkers are combined with MagMOF, respectively. They can be utilized as a hybrid sensing platform for the detection of CK-MB, Mb, and CTn I with high sensitivity (the limit of detection (LOD) for CK-MB is 174.98 U L–1 , for CTn I is 0.16 mg L–1 , and for Mb is 0.94 mg L–1 ). The detection ranges of MagMOF toward CK-MB, Mb, and CTn I in human serum have covered their maximum normal range in the human body, respectively. Further, MagMOF was applied in the ratiometric detection of aspirin with high sensitivity and low limit detection (LOD = 0.43 μM). As a result, MagMOF is the first example of realizing stable, susceptible, fast, and convenient detection of these AMI biomarkers and curing drug aspirin. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF